Skip to content

Quick ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.3×+0.1×
Myriad Genetics logo
Myriad GeneticsMYGN
2.2×+0.5×
Labcorp Holdings logo
Labcorp HoldingsLH
1.5×-0.1×
Quest Diagnostics logo
Quest DiagnosticsDGX
1.1×-0.2×
NeoGenomics logo
NeoGenomicsNEO
4.1×+2.1×
Natera, Inc. logo
Natera, Inc.NTRA
2.8×-0.9×

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Calculated from Fulgent Genetics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s quick ratio?
Fulgent Genetics, Inc. (FLGT) reported quick ratio of 5.3× in Q1 2026.
How has Fulgent Genetics, Inc.'s quick ratio changed year-over-year?
Fulgent Genetics, Inc.'s quick ratio decreased by 15.9% year-over-year, from 6.3× to 5.3×.
What is the long-term trend for Fulgent Genetics, Inc.'s quick ratio?
Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s quick ratio has grown at a 10.0% compound annual growth rate (CAGR), from 4× to 6.5×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.